NDT Advance Access published online on January 23, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfk062
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Nephrology, General Hospital of Wiener Neustadt, A-2700 Wiener Neustadt, Austria
* To whom correspondence should be addressed.
Received June 12, 2005
Accepted December 21, 2005
Interesting Case
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
Thomas Grobner 1 *
Thomas Grobner, E-mail: dr.thomas.grobner{at}aon.at
This article has no Abstract.
Keywords:
end stage renal disease; gadolinium-DTPA; metabolic acidosis; nephrogenic fibrosing dermopathy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. F. MORA Systemic Sclerosis: Environmental Factors J Rheumatol, November 1, 2009; 36(11): 2383 - 2396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Hope, W. A. High, P. E. LeBoit, B. Chaopathomkul, V. S. Rogut, R. J. Herfkens, and R. C. Brasch Nephrogenic Systemic Fibrosis in Rats Treated with Erythropoietin and Intravenous Iron Radiology, November 1, 2009; 253(2): 390 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Altun, D. R. Martin, R. Wertman, A. Lugo-Somolinos, E. R. Fuller 3rd, and R. C. Semelka Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy--Report from Two U.S. Universities Radiology, October 7, 2009; (2009) radiol.2533090649v2. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1407 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mannelli, S. Kim, C. H. Hajdu, J. S. Babb, T. W. I. Clark, and B. Taouli Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted Liver Am. J. Roentgenol., October 1, 2009; 193(4): 1044 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. U. Lee, C. M. Wood, G. K. Hesley, N. Leung, M. D. Bridges, J. T. Lund, P. U. Lee, and M. R. Pittelkow Large Sample of Nephrogenic Systemic Fibrosis Cases From a Single Institution Arch Dermatol, October 1, 2009; 145(10): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kreuter, S. Hoxtermann, T. Gambichler, C. Tigges, S. A. Hahn, and G. Schieren Detection of Clonal T Cells in the Circulation of Patients With Nephrogenic Systemic Fibrosis Arch Dermatol, October 1, 2009; 145(10): 1164 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. High Estimates of Risk, Empirical Treatment Observations, and Unexpected Laboratory Findings Reveal the Complexity of Nephrogenic Systemic Fibrosis Arch Dermatol, October 1, 2009; 145(10): 1178 - 1182. [Full Text] [PDF]
|
|
|
|
|
|
H. H. Abujudeh, R. Kaewlai, A. Kagan, L. B. Chibnik, R. M. Nazarian, W. A. High, and J. Kay Nephrogenic Systemic Fibrosis after Gadopentetate Dimeglumine Exposure: Case Series of 36 Patients Radiology, October 1, 2009; 253(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Prince, H. L. Zhang, J. C. Prowda, M. E. Grossman, and D. N. Silvers Nephrogenic Systemic Fibrosis and Its Impact on Abdominal Imaging RadioGraphics, October 1, 2009; 29(6): 1565 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Lim, P. Storey, I. P. Atanasova, J. Xu, E. M. Hecht, J. S. Babb, D. R. Stoffel, H. Chang, K. McGorty, Q. Chen, et al. Three-dimensional Electrocardiographically Gated Variable Flip Angle FSE Imaging for MR Angiography of the Hands at 3.0 T: Initial Experience Radiology, September 1, 2009; 252(3): 874 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Lanzman, A. Voiculescu, C. Walther, A. Ringelstein, X. Bi, P. Schmitt, S.-M. Freitag, S. Won, A. Scherer, and D. Blondin ECG-gated Nonenhanced 3D Steady-State Free Precession MR Angiography in Assessment of Transplant Renal Arteries: Comparison with DSA Radiology, September 1, 2009; 252(3): 914 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Morris, Y. Zhang, H. Zhang, J. C. Prowda, D. N. Silvers, R. A. Fawwaz, and M. R. Prince Features of Nephrogenic Systemic Fibrosis on Radiology Examinations Am. J. Roentgenol., July 1, 2009; 193(1): 61 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jarvelainen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy Pharmacol. Rev., June 1, 2009; 61(2): 198 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Bridges, B. S. St. Amant, R. B. McNeil, J. G. Cernigliaro, J. P. Dwyer, and P. M. Fitzpatrick High-Dose Gadodiamide for Catheter Angiography and CT in Patients With Varying Degrees of Renal Insufficiency: Prevalence of Subsequent Nephrogenic Systemic Fibrosis and Decline in Renal Function Am. J. Roentgenol., June 1, 2009; 192(6): 1538 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, M. Jain, A. B. Harris, V. S. Lee, J. S. Babb, E. E. Sigmund, L. E. Rueff, and B. Taouli T1 Hyperintense Renal Lesions: Characterization with Diffusion-weighted MR Imaging versus Contrast-enhanced MR Imaging Radiology, June 1, 2009; 251(3): 796 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kribben, O. Witzke, U. Hillen, J. Barkhausen, A. E. Daul, and R. Erbel Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J. Am. Coll. Cardiol., May 5, 2009; 53(18): 1621 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gossner, M. R. Prince, H. Zhang, M. Morris, C. M. Magro, and R. L. DeLapaz Is Nephrogenic Systemic Fibrosis Linked to the Introduction of Contrast-enhanced MR Angiography? Radiology, May 1, 2009; 251(2): 612 - 613. [Full Text] [PDF]
|
|
|
|
|
|
B. Taouli, R. K. Thakur, L. Mannelli, J. S. Babb, S. Kim, E. M. Hecht, V. S. Lee, and G. M. Israel Renal Lesions: Characterization with Diffusion-weighted Imaging versus Contrast-enhanced MR Imaging Radiology, May 1, 2009; 251(2): 398 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Steen, E. Giannitsis, C. Sommerer, U. Bahner, M. Brandl, C. Merbach, C. Merten, E. Ritz, H. A. Katus, M. Zeier, et al. Acute phase reaction to gadolinium-DTPA in dialysis patients Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1274 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Roditi MRI contrast agent safety in renal impairment Clin Risk, March 1, 2009; 15(2): 47 - 53. [Full Text] [PDF]
|
|
|
|
|
|
R. Agarwal, S. M. Brunelli, K. Williams, M. D. Mitchell, H. I. Feldman, and C. A. Umscheid Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis Nephrol. Dial. Transplant., March 1, 2009; 24(3): 856 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bangsgaard, P. Marckmann, K. Rossen, and L. Skov Nephrogenic Systemic Fibrosis: Late Skin Manifestations Arch Dermatol, February 1, 2009; 145(2): 183 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H S SU, R M NAZARIAN, and J A SCOTT Appearance of nephrogenic fibrosing dermopathy on a bone scan Br. J. Radiol., February 1, 2009; 82(974): e35 - e36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Silverman, J. R. Leyendecker, and E. S. Amis Jr What Is the Current Role of CT Urography and MR Urography in the Evaluation of the Urinary Tract? Radiology, February 1, 2009; 250(2): 309 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Perez-Rodriguez, S. Lai, B. D. Ehst, D. M. Fine, and D. A. Bluemke Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment--Report of 33 Cases Radiology, February 1, 2009; 250(2): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Perazella Current Status of Gadolinium Toxicity in Patients with Kidney Disease Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 461 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The year in cardiac imaging. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70. [Full Text] [PDF]
|
|
|
|
|
|
K. Juluru, J. Vogel-Claussen, K. J. Macura, I. R. Kamel, A. Steever, and D. A. Bluemke Quality Initiatives MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety1 RadioGraphics, January 1, 2009; 29(1): 9 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. De Wilde, P. Peeters, M. Praet, M. Petrovic, and R. Vanholder Contrast-enhanced ultrasonography with microbubbles for successful screening of kidney tumours NDT Plus, December 1, 2008; 1(6): 469 - 470. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Wiginton Implications of NSF-Active and NSF-Inert in Nephrogenic Systemic Fibrosis Am. J. Roentgenol., December 1, 2008; 191(6): 1864 - 1866. [Full Text] [PDF]
|
|
|
|
 |
|
 J Kay Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii66 - iii69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Juluru, J. Vogel-Claussen, K. J. Macura, I. R. Kamel, A. Steever, and D. A. Bluemke MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety RadioGraphics, November 19, 2008; (2008) 291085072. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Chiribiri, S. Kelle, U. Kohler, L. F. Tops, B. Schnackenburg, R. Bonamini, J. J. Bax, E. Fleck, and E. Nagel Magnetic resonance cardiac vein imaging: relation to mitral valve annulus and left circumflex coronary artery. J. Am. Coll. Cardiol. Img., November 1, 2008; 1(6): 729 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.P. Lim, M. Shapiro, E.Y. Wang, M. Law, J.S. Babb, L.E. Rueff, J.S. Jacob, S. Kim, R.H. Carson, T.P. Mulholland, et al. 3D Time-Resolved MR Angiography (MRA) of the Carotid Arteries with Time-Resolved Imaging with Stochastic Trajectories: Comparison with 3D Contrast-Enhanced Bolus-Chase MRA and 3D Time-Of-Flight MRA AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1847 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zelasko, M. Hollingshead, M. Castillo, and T.W. Bouldin CT and MR Imaging of Progressive Dural Involvement by Nephrogenic Systemic Fibrosis AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1880 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Weinreb Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT? Radiology, October 1, 2008; 249(1): 3 - 8. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Halvorsen Which Study When? Iodinated Contrast-enhanced CT Versus Gadolinium-enhanced MR Imaging Radiology, October 1, 2008; 249(1): 9 - 15. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Silverman, G. M. Israel, B. R. Herts, and J. P. Richie Management of the Incidental Renal Mass Radiology, October 1, 2008; 249(1): 16 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Shellock and A. Spinazzi MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis Am. J. Roentgenol., October 1, 2008; 191(4): 1129 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Colletti Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm Am. J. Roentgenol., October 1, 2008; 191(4): 1150 - 1153. [Full Text] [PDF]
|
|
|
|
|
|
R. Agid, R.A. Willinsky, S.-K. Lee, K.G. TerBrugge, and R.I. Farb Characterization of Aneurysm Remnants after Endovascular Treatment: Contrast-Enhanced MR Angiography versus Catheter Digital Subtraction Angiography AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1570 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Prince, H. Zhang, M. Morris, J. L. MacGregor, M. E. Grossman, J. Silberzweig, R. L. DeLapaz, H. J. Lee, C. M. Magro, and A. M. Valeri Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers Radiology, September 1, 2008; 248(3): 807 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wertman, , BA, E. Altun, D. R. Martin, D. G. Mitchell, J. R. Leyendecker, R. B. O'Malley, D. J. Parsons, E. R. Fuller III, and R. C. Semelka Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities Radiology, September 1, 2008; 248(3): 799 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M E ABOU EL-GHAR, A A SHOKEIR, H F REFAIE, and T A EL-DIASTY MRI in patients with chronic obstructive uropathy and compromised renal function: a sole method for morphological and functional assessment Br. J. Radiol., August 1, 2008; 81(968): 624 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Schietinger, G. M. Brammer, H. Wang, J. M. Christopher, K. W. Kwon, A. J. Mangrum, J. M. Mangrum, and C. M. Kramer Patterns of late gadolinium enhancement in chronic hemodialysis patients. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 450 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Rofsky Nephrogenic systemic fibrosis: considerations for the cardiologist. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 457 - 459. [Full Text] [PDF]
|
|
|
|
|
|
M. Miyazaki and V. S. Lee Nonenhanced MR Angiography Radiology, July 1, 2008; 248(1): 20 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Schroeder, C. Weingart, B. Coras, I. Hausser, S. Reinhold, M. Mack, V. Seybold, T. Vogt, B. Banas, F. Hofstaedter, et al. Ultrastructural Evidence of Dermal Gadolinium Deposits in a Patient with Nephrogenic Systemic Fibrosis and End-Stage Renal Disease Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ersoy and F. J. Rybicki MR Angiography of the Lower Extremities Am. J. Roentgenol., June 1, 2008; 190(6): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Reilly Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term Hemodialysis Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 747 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Perazella How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease? Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 649 - 651. [Full Text] [PDF]
|
|
|
|
|
|
G. Zaharchuk, A.J. Martin, and W.P. Dillon Noninvasive Imaging of Quantitative Cerebral Blood Flow Changes during 100% Oxygen Inhalation Using Arterial Spin-Labeling MR Imaging AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 663 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Kane, A. W. Stanson, D. Kalnicka, D. W. Rosenthal, C. U. Lee, S. C. Textor, and V. D. Garovic Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1233 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Wiginton, B. Kelly, A. Oto, M. Jesse, P. Aristimuno, R. Ernst, and G. Chaljub Gadolinium-Based Contrast Exposure, Nephrogenic Systemic Fibrosis, and Gadolinium Detection in Tissue Am. J. Roentgenol., April 1, 2008; 190(4): 1060 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Golding and J. M. Provenzale Nephrogenic Systemic Fibrosis: Possible Association with a Predisposing Infection Am. J. Roentgenol., April 1, 2008; 190(4): 1069 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Shabana, R. H. Cohan, J. H. Ellis, H. K. Hussain, I. R. Francis, L. D. Su, S. K. Mukherji, and R. D. Swartz Nephrogenic Systemic Fibrosis: A Report of 29 Cases Am. J. Roentgenol., March 1, 2008; 190(3): 736 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kay, H. Bazari, L. L. Avery, and A. F. Koreishi Case 6-2008 -- A 46-Year-Old Woman with Renal Failure and Stiffness of the Joints and Skin N. Engl. J. Med., February 21, 2008; 358(8): 827 - 838. [Full Text] [PDF]
|
|
|
|
 |
|
 N. ISSA, E. D. POGGIO, R. A. FATICA, R. PATEL, P. M. RUGGIERI, and R. J. HEYKA Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI Cleveland Clinic Journal of Medicine, February 1, 2008; 75(2): 95 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Leyendecker, C. E. Barnes, and R. J. Zagoria MR Urography: Techniques and Clinical Applications RadioGraphics, January 1, 2008; 28(1): 23 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Stepansky, E. M. Hecht, R. Rivera, L. E. Hirsh, B. Taouli, M. Kaur, and V. S. Lee Dynamic MR Angiography of Upper Extremity Vascular Disease: Pictorial Review RadioGraphics, January 1, 2008; 28(1): e28 - e28. [Abstract] [Full Text]
|
|
|
|
|
|
P. Marckmann, L. Skov, K. Rossen, J. G. Heaf, and H. S. Thomsen Case-control study of gadodiamide-related nephrogenic systemic fibrosis Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3174 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Nortier and V. del Marmol Nephrogenic systemic fibrosis the need for a multidisciplinary approach Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3097 - 3101. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Othersen, J. C. Maize Jr., R. F. Woolson, and M. N. Budisavljevic Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3179 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.M. Morris and G.M. Miller Increased Signal in the Subarachnoid Space on Fluid-Attenuated Inversion Recovery Imaging Associated with the Clearance Dynamics of Gadolinium Chelate: A Potential Diagnostic Pitfall AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1964 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Remy-Jardin, M. Pistolesi, L. R. Goodman, W. B. Gefter, A. Gottschalk, J. R. Mayo, and H. D. Sostman Management of Suspected Acute Pulmonary Embolism in the Era of CT Angiography: A Statement from the Fleischner Society Radiology, November 1, 2007; 245(2): 315 - 329. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Thakral and J. L. Abraham Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of Gadolinium deposits in skin J. Electron Microsc. (Tokyo), October 19, 2007; (2007) dfm020v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Collidge, P. C. Thomson, P. B. Mark, J. P. Traynor, A. G. Jardine, S. T. W. Morris, K. Simpson, and G. H. Roditi Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort Radiology, October 1, 2007; 245(1): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Swaminathan and S. V. Shah New Insights into Nephrogenic Systemic Fibrosis J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2636 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saab, A. Abu-Alfa, E. A. Sadowski, and A. Djamali Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis? Radiology, September 1, 2007; 244(3): 930 - 932. [Full Text] [PDF]
|
|
|
|
 |
|
 A. S Peak and A. Sheller Risk Factors for Developing Gadolinium-Induced Nephrogenic Systemic Fibrosis Ann. Pharmacother., September 1, 2007; 41(9): 1481 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Swaminathan, T. D. Horn, D. Pellowski, S. Abul-Ezz, J. A. Bornhorst, S. Viswamitra, and S. V. Shah Nephrogenic Systemic Fibrosis, Gadolinium, and Iron Mobilization N. Engl. J. Med., August 16, 2007; 357(7): 720 - 722. [Full Text] [PDF]
|
|
|
|
|
|
H. Richmond, J. Zwerner, Y. Kim, and D. Fiorentino Nephrogenic Systemic Fibrosis: Relationship to Gadolinium and Response to Photopheresis Arch Dermatol, August 1, 2007; 143(8): 1025 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. DeLoach and E. R. Mohler III Peripheral Arterial Disease: A Guide for Nephrologists Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 839 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C Thomson, T. A Collidge, P. B Mark, and J. P Traynor Gadolinium contrast may be risky in kidney disease BMJ, June 30, 2007; 334(7608): 1335 - 1336. [Full Text] [PDF]
|
|
|
|
|
|
E. Kanal, A. J. Barkovich, C. Bell, J. P. Borgstede, W. G. Bradley Jr., J. W. Froelich, T. Gilk, J. R. Gimbel, J. Gosbee, E. Kuhni-Kaminski, et al. ACR Guidance Document for Safe MR Practices: 2007 Am. J. Roentgenol., June 1, 2007; 188(6): 1447 - 1474. [Full Text] [PDF]
|
|
|
|
|
|
J. H. Maki, G. J. Wilson, W. B. Eubank, D. J. Glickerman, J. A. Millan, and R. M. Hoogeveen Navigator-Gated MR Angiography of the Renal Arteries: A Potential Screening Tool for Renal Artery Stenosis Am. J. Roentgenol., June 1, 2007; 188(6): W540 - W546. [Abstract] [Full Text] [PDF]
|
|